- Home
- SER vs GSIW Comparison
SER vs GSIW Comparison
Compare SER & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SER | GSIW |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.0M | 33.9M |
| IPO Year | 2018 | 2023 |
Fundamental Metrics
Financial Performance| Metric | SER | GSIW |
|---|---|---|
| Price | $3.10 | $0.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | 15.1K | ★ 355.3K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $116,000.00 | ★ $5,368,221.00 |
| Revenue This Year | $134.46 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 283.23 |
| 52 Week Low | $3.12 | $0.09 |
| 52 Week High | $7.92 | $1.79 |
Technical Indicators
Market Signals| Indicator | SER | GSIW |
|---|---|---|
| Relative Strength Index (RSI) | 29.42 | 39.86 |
| Support Level | $3.15 | $0.14 |
| Resistance Level | $4.26 | $0.15 |
| Average True Range (ATR) | 0.23 | 0.01 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Price Performance
Historical ComparisonAbout SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.